BioClinica Signs Agreements with TauRx for a Series of Expanded Trials
Nov 07 - 2012 02:45 PM
Earlier this week, a global provider of clinical trial management solutions, BioClinica, Inc., announced that in order to use Trident IWR/IVR and Imaging Core Lab (ICL) solutions to support its upcoming Phase III clinical trials, TauRx Therapeutics has signed agreements with BioClinica.
Zillion Magazine (December 2014) - 'A Novel Approach to Alzheimer's Disease'
Oct 30 - 2012 03:11 PM
TauRx Chairman Claude Wischik was interviewed by Zillion, an Amsterdam-based publication, about the Phase III clinical trials (see the article below).
Das blaue Wunder Das blaue Wunder
Aug 28 - 2008 07:00 AM
Ein alter Farbstoff soll die Alzheimersche Krankheit lindern. Die Fachwelt rätselt, ob es sich um eine Ente handelt - oder um eine sensationelle Entdeckung
Slowing mental ravages of Alzheimer's disease
Aug 01 - 2008 11:00 AM
Hope is often scarce in research on Alzheimer's disease, but a study released Tuesday at a Chicago medical conference offered tentative hope for a new way of slowing elderly patients' mental decline.
Daily pill that halts Alzheimer's is hailed as 'biggest breakthrough against disease for 100 years'
Jul 30 - 2008 05:45 AM
A new drug halts the devastating progress of Alzheimer’s disease, say British scientists.